Mimix™ Prostate Cancer Panel Negative Control, cfDNA Reference Standard

The Prostate Cancer Panel cfDNA Reference Standard (Negative Control) is a well characterized, cell line-derived control material manufactured under ISO:13485 that is negative for 17 variants (except CNV in AR Gene) across 9 genes clinically relevant to prostate cancer.

Clearance sale: Discounted pricing on selected cfDNA inventory. Limited availability.*

*This pricing promotion is only valid on selected products and while stocks last. Not valid in Italy and China. The promotion cannot be combined with any other promotions, discounts, or offers. Conditions of the promotions may change, and Revvity may void, change, cancel, suspend, or amend this promotion without notice.